Skip to main content
. 2024 Nov 21;7(11):e2446325. doi: 10.1001/jamanetworkopen.2024.46325

Table 1. Patient Characteristics.

Characteristic Patients, No. (%)
Laparotomy arm (nā€‰=ā€‰51) MIS arm (nā€‰=ā€‰49)
Age, median (IQR), y 63 (57-70) 61 (55-68)
Racea
Asian 1 (2) 3 (6)
Black or African American 3 (6) 0
White 46 (90) 44 (90)
Otherb 1 (2) 2 (4)
Ethnicitya
Hispanic or Latino 15 (29) 18 (37)
Not Hispanic or Latino 36 (71) 31 (63)
Primary tumor
Ovary 40 (78) 42 (86)
Fallopian tube 2 (4) 0
Peritoneum 9 (18) 7 (14)
Histologic type
Serous 48 (94) 46 (94)
Other high-grade adenocarcinomas 3 (6) 1 (2)
Unknown 0 2 (4)
Preoperative BRCA status
Wild type 25 (49) 25 (51)
BRCA1 mutated 5 (10) 3 (6)
BRCA2 mutated 3 (6) 6 (12)
Unknown 18 (35) 15 (30)
Cancer stage
IIIC 34 (67) 33 (67)
IVA 8 (16) 9 (18)
IVB 9 (17) 7 (15)
MIS approach
Traditional laparoscopy NA 48 (98)
Robotic NA 1 (2)
Planned HIPEC
No 40 (78) 40 (82)
Yes 11 (22) 9 (18)
Surgical complexity score, median (IQR) 2 (1-3) 2 (1-3)

Abbreviations: HIPEC, hyperthermic intraperitoneal chemotherapy; MIS, minimally invasive surgery; NA, not applicable.

a

Race and ethnicity were self-reported by patients.

b

Other category included unknown.